Caris
Caris Life Sciences, Ontada Ink Deal to Integrate Genomic, Clinical Cancer Data
The firms will combine Caris' multimodal genomic data with Ontada's community oncology-based real-world data to support cancer drug development.
People in the News at GenomOncology, Translational Genomics Research Institute, and Caris
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
People in the News at GeneDx, Caris Life Sciences, Gordon and Betty Moore Foundation, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Caris Life Sciences Expands Access to Urologic Cancer Tests Through Deal With Lumea
The firms agreed to make Caris' whole-exome and whole-transcriptome sequencing tests available through Lumea's BxLink digital pathology software.
Caris Life Sciences CDx Assay Nabs FDA Approval
The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.